SOURCE: Equity News Circuit

Equity News Circuit

January 14, 2013 08:15 ET

Free Research Reports on ARQL, BBY, CATM and DNDN Issued by the Bedford Report

Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT

NEW YORK, NY--(Marketwire - Jan 14, 2013) - The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

ArQule, Inc. (NASDAQ: ARQL) is engaged in the research and development of cancer therapeutics. Shares of the company fell sharply Friday after reporting their lead drug candidate Tivantinib did not meet its primary endpoint in a recent Phase 2 trial.

Find out more about ArQule including full access to the free equity report at:

Best Buy Co., Inc. (NYSE: BBY) shares of the electronics retailer soared over 16 percent on 4.5 times the average daily volume Friday. The company's holiday sales were driven by a strong performance in domestic sales which totaled $9.9 billion for the nine weeks ended January 5, 2013.

Find out more about Best Buy including full access to the free equity report at:

Cardtronics, Inc. (NASDAQ: CATM) shares surged 6 percent on nearly double the average daily volume Friday. Analysts J.P. Morgan have recently upgraded the company's rating from "neutral" to "overweight."

Find out more about Cardtronics including full access to the free equity report at:

Dendreon Corporation (NASDAQ: DNDN) shares soared 21 percent on more six-times the average daily volume Friday. Sanford C. Bernstein & Co. analyst Geoffrey Porges recently raised his peak revenue forecast for Provenge, the company's prostate cancer drug, to $799 million by 2017, his previous forecast was $580 million.

Find out more about Dendreon including full access to the free equity report at:

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Providence Media Strategies LLC has paid Equity News Circuit four hundred and fifty dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information